{"id":239638,"date":"2026-06-25T22:06:57","date_gmt":"2026-06-26T03:06:57","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/06\/preventing-the-next-pandemic-using-ai-designed-vaccines"},"modified":"2026-06-25T22:06:57","modified_gmt":"2026-06-26T03:06:57","slug":"preventing-the-next-pandemic-using-ai-designed-vaccines","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/06\/preventing-the-next-pandemic-using-ai-designed-vaccines","title":{"rendered":"Preventing the next pandemic using AI-designed vaccines"},"content":{"rendered":"

<\/a><\/p>\n

For most of human history, infectious diseases were the main causes of morbidity and mortality. Advances in sanitation, antibiotics, vaccines, and public health dramatically shifted that balance, particularly in high-income countries, where life expectancy has increased by nearly 40 years over the past century<\/a>. Yet the COVID-19 pandemic provided a stark reminder that infectious threats can still reshape societies almost overnight. Between 2019 and 2021 alone, life expectancy in the US fell by more than two years<\/a>, and recent modelling suggests there is roughly a 50 percent<\/a> chance of another COVID-scale pandemic occurring within the next 25 years.<\/p>\n

Historically, the vaccine development model has been largely reactive and variant-driven, but the industry is now actively shifting toward proactive and universal vaccinology to get ahead of evolving pathogens. Recent results from a first-in-human clinical trial led by the University of Cambridge and its spin-out DIOSynVax<\/a>, published<\/a> in the Journal of Infection<\/em>, provide early clinical evidence of this shift, demonstrating the safety of an AI-designed \u201csuper-antigen\u201d intended to provide broad viral coverage.<\/p>\n","protected":false},"excerpt":{"rendered":"

For most of human history, infectious diseases were the main causes of morbidity and mortality. Advances in sanitation, antibiotics, vaccines, and public health dramatically shifted that balance, particularly in high-income countries, where life expectancy has increased by nearly 40 years over the past century. Yet the COVID-19 pandemic provided a stark reminder that infectious threats [\u2026]<\/p>\n","protected":false},"author":599,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495,6],"tags":[],"class_list":["post-239638","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/239638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/599"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=239638"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/239638\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=239638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=239638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=239638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}